Understanding and targeting Alzheimer’s disease, 5-8 May 2019
09:00 5th May 2019 to 18:00 8th May 2019
Rungstedgaard, Rungsted Strandvej 107, 2960 Rungsted Kyst

The Lundbeck Foundation has 20 free seats for the conference.

Apply by sending an e-mail to with name, title, institution and age.

Deadline is February 27, 2019

To be considered, the applicant must be based in Denmark, below 40 years, bring an abstract and participate in the entire meeting.

It will be first come, first serve and we will inform the applicants after the deadline by mail whether they have received a free seat or not. The list of applicants will be forwarded to the FENS organizers.

The applicants must then register themselves and enclose their abstract using online application portal to FENS Brain conference

Rungstedgaard, North of Copenhagen, Denmark

Dementia poses one of the largest health and economic problems in the world with over 50 million people worldwide living with dementia, no disease modifying treatments available, and numbers set to dramatically increase as our population ages. Neuroscience research has the real potential to change this bleak future and develop effective ways to prevent or treat the diseases that cause dementia.

Three of our current grand challenges towards this goal are to understand why certain brain regions are susceptible to the accumulation of pathology and neurodegeneration early in Alzheimer’s disease and related dementias, how pathologies then spread from these vulnerable regions to damage the rest of the brain, and finally how risk factors like ApoE modulate disease progression.

In this meeting, we will address the best way to move forward as a field in addressing these knowledge gaps with an emphasis on the emerging data in the field implicating non-neuronal contributors to disease risk and regional vulnerability.  The latest clinical trials and the requirement of biomarkers for early risk assessment will be discussed on the background of our understanding of disease mechanisms.  The meeting will end with a podiums discussion on the pros and cons of the amyloid cascade hypothesis.


  • Federation of European Neuroscience Societies

Other Organizer


Share our event